CX Institutional’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $997K | Buy |
2,234
+285
| +15% | +$134K | 0.03% | 335 |
|
|
2026
Q1 | $773K | Sell |
1,949
-35
| -2% | -$15.8K | 0.02% | 376 |
|
|
2025
Q4 | $932K | Buy |
1,984
+71
| +4% | +$31.5K | 0.03% | 300 |
|
|
2025
Q3 | $944K | Buy |
1,913
+76
| +4% | +$43K | 0.03% | 307 |
|
|
2025
Q2 | $942K | Sell |
1,837
-251
| -12% | -$117K | 0.03% | 274 |
|
|
2025
Q1 | $895K | Sell |
2,088
-396
| -16% | -$192K | 0.03% | 282 |
|
|
2024
Q4 | $1.21M | Buy |
2,484
+1,110
| +81% | +$580K | 0.05% | 230 |
|
|
2024
Q3 | $696K | Buy |
1,374
+17
| +1% | +$9.12K | 0.03% | 331 |
|
|
2024
Q2 | $807K | Buy |
1,357
+428
| +46% | +$242K | 0.04% | 308 |
|
|
2024
Q1 | $531K | Sell |
929
-11
| -1% | -$6.05K | 0.03% | 361 |
|
|
2023
Q4 | $484K | Sell |
940
-7
| -0.7% | -$3.58K | 0.03% | 332 |
|
|
2023
Q3 | $435K | Buy |
947
+185
| +24% | +$82.8K | 0.02% | 347 |
|
|
2023
Q2 | $332K | Buy |
762
+53
| +7% | +$21.3K | 0.02% | 412 |
|
|
2023
Q1 | $275K | Sell |
709
-49
| -6% | -$17.5K | 0.01% | 425 |
|
|
2022
Q4 | $242K | Buy |
+758
| New | +$237K | 0.01% | 470 |
|
|
2022
Q3 | – | Sell |
-418
| Closed | -$127K | – | 1030 |
|
|
2022
Q2 | $127K | Buy |
+418
| New | +$126K | 0.01% | 506 |
|
|
2021
Q4 | – | Sell |
-406
| Closed | -$122K | – | 814 |
|
|
2021
Q3 | $122K | Buy |
406
+30
| +8% | +$9.11K | 0.01% | 413 |
|
|
2021
Q2 | $104K | Buy |
376
+109
| +41% | +$27.7K | 0.01% | 431 |
|
|
2021
Q1 | $66K | Buy |
267
+24
| +10% | +$6.09K | 0.01% | 439 |
|
|
2020
Q4 | $63K | Buy |
243
+65
| +37% | +$15K | 0.01% | 411 |
|
|
2020
Q3 | $38K | Buy |
178
+16
| +10% | +$3.26K | ﹤0.01% | 434 |
|
|
2020
Q2 | $32K | Buy |
162
+43
| +36% | +$7.1K | ﹤0.01% | 379 |
|
|
2020
Q1 | $15K | Buy |
119
+15
| +14% | +$2.13K | ﹤0.01% | 415 |
|
|
2019
Q4 | $14K | Sell |
104
-20
| -16% | -$2.74K | ﹤0.01% | 396 |
|
|
2019
Q3 | $17K | Buy |
124
+49
| +65% | +$6.63K | ﹤0.01% | 395 |
|
|
2019
Q2 | $10K | Buy |
75
+20
| +36% | +$2.41K | ﹤0.01% | 493 |
|
|
2019
Q1 | $6K | Buy |
55
+35
| +175% | +$3.47K | ﹤0.01% | 527 |
|
|
2018
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 462 |
|
|
2018
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 329 |
|
|
2018
Q2 | $2K | Buy |
+20
| New | +$1.74K | ﹤0.01% | 304 |
|
Other funds holding SNPS
NC
CX Institutional's SNPS Position: Q2 2026 in Review
CX Institutional increased its Synopsys (SNPS) stake by 15% in Q2 2026, buying an estimated $134K and bringing the position to 2,234 shares worth $997K. The position accounts for 0.03% of the portfolio, ranked #335.
CX Institutional first reported a position in SNPS in Q2 2018 and has held it in 30 quarters since. The position peaked at $1.21M in Q4 2024. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.
- CX Institutional held 2,234 shares of Synopsys worth $997K as of Q2 2026.
- CX Institutional bought 285 Synopsys shares in Q2 2026, an estimated $134K.
- Synopsys made up 0.03% of CX Institutional's portfolio in Q2 2026, its #335 holding.
- CX Institutional first reported a position in Synopsys in Q2 2018 and has held it in 30 quarters since.
- CX Institutional's Synopsys position peaked at $1.21M in Q4 2024.
- 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.